Urinary NGAL and KIM-1 Are the Early Detecting Biomarkers of Preterm Infants with Acute Kidney Injury

Hong-zhu Lu, Qihong Fan, Lu Wang, Nipun Shrestha, Sijan Thapa
{"title":"Urinary NGAL and KIM-1 Are the Early Detecting Biomarkers of Preterm Infants with Acute Kidney Injury","authors":"Hong-zhu Lu, Qihong Fan, Lu Wang, Nipun Shrestha, Sijan Thapa","doi":"10.4236/YM.2019.33019","DOIUrl":null,"url":null,"abstract":"Background: Acute kidney injury (AKI) is common in neonates. However, early diagnosis is difficult. Different biomarkers for early diagnosis of AKI, such as NGAL, KIM-1, Cys-C, IL-18, β2-microglobulin have been proposed. But regarding premature infant, there is very little research that has been reported. Objectives: To investigate the role of urinary NGAL and Kim-1 biomarkers for early diagnosis of AKI in premature neonates. Methods: Eighty cases were divided into experimental group (60 cases) and controls group (20 cases). Of 60 cases, 24 patients met the criteria for AKI group; the remaining 36 were non-AKI group. Blood and urine samples, 1 ml each, were collected from all subjects at first day, second day, third day and seventh day of life. Urine NGAL and KIM-1 were measured by ELISA. Results: The urinary NGAL and KIM-1 are significantly higher in AKI group than Non-AKI group and normal control group in the first three days. They present earlier than classical Scr. Conclusion: Urinay NGAL and Kim-1 are beneficial biomarkers for the early diagnosis of AKI in preterm neonates.","PeriodicalId":57748,"journal":{"name":"长江医药(英文)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"长江医药(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4236/YM.2019.33019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Background: Acute kidney injury (AKI) is common in neonates. However, early diagnosis is difficult. Different biomarkers for early diagnosis of AKI, such as NGAL, KIM-1, Cys-C, IL-18, β2-microglobulin have been proposed. But regarding premature infant, there is very little research that has been reported. Objectives: To investigate the role of urinary NGAL and Kim-1 biomarkers for early diagnosis of AKI in premature neonates. Methods: Eighty cases were divided into experimental group (60 cases) and controls group (20 cases). Of 60 cases, 24 patients met the criteria for AKI group; the remaining 36 were non-AKI group. Blood and urine samples, 1 ml each, were collected from all subjects at first day, second day, third day and seventh day of life. Urine NGAL and KIM-1 were measured by ELISA. Results: The urinary NGAL and KIM-1 are significantly higher in AKI group than Non-AKI group and normal control group in the first three days. They present earlier than classical Scr. Conclusion: Urinay NGAL and Kim-1 are beneficial biomarkers for the early diagnosis of AKI in preterm neonates.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
尿NGAL和KIM-1是早产儿急性肾损伤的早期检测生物标志物
背景:急性肾损伤(AKI)在新生儿中很常见。然而,早期诊断是困难的。不同的生物标志物如NGAL、KIM-1、Cys-C、IL-18、β2-微球蛋白等已被提出用于AKI的早期诊断。但是关于早产儿的研究却很少。目的:探讨尿NGAL和Kim-1生物标志物在早产儿AKI早期诊断中的作用。方法:80例患者分为实验组(60例)和对照组(20例)。60例患者中,24例符合AKI组标准;其余36例为非aki组。所有受试者在出生第1天、第2天、第3天和第7天采集血样和尿样,各1 ml。ELISA法检测尿NGAL和KIM-1。结果:AKI组患者前3天尿NGAL和KIM-1水平明显高于非AKI组和正常对照组。它们比经典Scr出现得更早。结论:尿NGAL和Kim-1是早期诊断早产儿AKI的有益生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
104
期刊最新文献
NLRP3 Inflammasome in Relation to Glucose and Lipid Metabolism, and Insulin Resistance in Diabetes and Pre-Diabetes Application of Wax Therapy in Pain Care of Patients with Rheumatoid Arthritis Risk Prediction Model for Surgical Treatment of Ruptured Corpus Luteum in the Ovary Advances of Genetic Testing Technology in Etiology Diagnosis of Recurrent Spontaneous Abortion Application of Clinical Nursing Pathway in the Peri-Treatment Period of Immunoadsorption Therapy for Rheumatic Immune Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1